Transcription Factor EB (TFEB) activity increases resistance of TNBC stem cells to metabolic stress

Breast Cancer Stem Cells (CSCs) are difficult to therapeutically target, but continued efforts are critical given their contribution to tumor heterogeneity and treatment resistance in Triple-Negative Breast Cancer (TNBC). CSC properties are influenced by metabolic stress, but specific mechanisms are lacking for effective drug intervention. Our previous work on TFEB suggested a key function in CSC metabolism. Indeed, TFEB knockdown (KD) inhibited mammosphere formation in vitro and tumor initiation/growth in vivo. These phenotypic effects were accompanied by a decline in CD44high/CD24low cells. Glycolysis inhibitor 2-deoxy-D-glucose (2-DG) induced TFEB nuclear translocation, indicative of TFEB transcriptional activity. TFEB KD blunted, whereas TFEB (S142A) augmented 2-DG-driven UPR mediators, notably BiP/HSPA5 and CHOP. Like TFEB KD, silencing BiP/HSPA5 inhibited CSC self-renewal, suggesting that TFEB augments UPR-related survival. Further studies showed that TFEB KD attenuated 2-DG-directed autophagy, suggesting a mechanism whereby TFEB protects CSCs against 2-DG-induced stress. Our data indicate that TFEB modulates CSC metabolic stress response via autophagy and UPR. These findings reveal the novel role of TFEB in regulating CSCs during metabolic stress in TNBC. Financial Support This work was supported by CPRIT Grant RR160093 (to S.G. Eckhardt), CPRIT Grant RP210088 (to K.N. Dalby), UT College of Pharmacy Non-discretionary Funds (to C. Van Den Berg), and UT Graduate Continuing Fellowship (to M. Soleimani).

[1]  I. Direito,et al.  The Clinicopathological Significance of BiP/GRP-78 in Breast Cancer: A Meta-Analysis of Public Datasets and Immunohistochemical Detection , 2022, Current oncology.

[2]  Shelly C. Lu,et al.  TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis , 2022, Nature Communications.

[3]  L. Carey,et al.  Triple negative breast cancer: Pitfalls and progress , 2022, NPJ breast cancer.

[4]  Milad Soleimani,et al.  Covalent JNK inhibitor, JNK-IN-8, suppresses tumor growth in triple-negative breast cancer by activating TFEB and TFE3 mediated lysosome biogenesis and autophagy. , 2022, Molecular cancer therapeutics.

[5]  R. V. Prasad,et al.  Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease , 2022, Cell Death & Differentiation.

[6]  H. Lim,et al.  Lysosomal Ca2+-mediated TFEB activation modulates mitophagy and functional adaptation of pancreatic β-cells to metabolic stress , 2022, Nature Communications.

[7]  F. Kruyt,et al.  The unfolded protein response as regulator of cancer stemness and differentiation: mechanisms and implications for cancer therapy. , 2021, Biochemical pharmacology.

[8]  R. Yao,et al.  The Role and Regulatory Mechanism of Transcription Factor EB in Health and Diseases , 2021, Frontiers in Cell and Developmental Biology.

[9]  Henry E. Miller,et al.  Correlation AnalyzeR: functional predictions from gene co-expression correlations , 2021, BMC Bioinform..

[10]  J. Kim,et al.  TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase , 2021, Cancers.

[11]  C. Spruck,et al.  Triple-negative breast cancer therapy: Current and future perspectives (Review) , 2020, International journal of oncology.

[12]  C. Criscitiello,et al.  Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies , 2020, NPJ breast cancer.

[13]  Yong Li,et al.  Triple-negative breast cancer therapeutic resistance: Where is the Achilles' heel? , 2020, Cancer letters.

[14]  Ursula Klingmüller,et al.  mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability , 2020, Nature Communications.

[15]  C. Hetz,et al.  Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.

[16]  M. Cristofanilli,et al.  The Landscape of Targeted Therapies in TNBC , 2020, Cancers.

[17]  Ian H. Guldner,et al.  Cell surface GRP78 promotes stemness in normal and neoplastic cells , 2020, Scientific Reports.

[18]  G. R. van den Brink,et al.  Expression of UPR effector proteins ATF6 and XBP1 reduce colorectal cancer cell proliferation and stemness by activating PERK signaling , 2019, Cell Death & Disease.

[19]  A. Ballabio,et al.  TFEB controls vascular development by regulating the proliferation of endothelial cells , 2018, The EMBO journal.

[20]  E. Ma,et al.  The transcription factors TFEB and TFE3 link the FLCN-AMPK signaling axis to innate immune response and pathogen resistance , 2018, bioRxiv.

[21]  S. Anant,et al.  Cancer Stem Cell Metabolism and Potential Therapeutic Targets , 2018, Front. Oncol..

[22]  A. Ballabio,et al.  The complex relationship between TFEB transcription factor phosphorylation and subcellular localization , 2018, The EMBO journal.

[23]  Yunping Luo,et al.  The three branches of the unfolded protein response exhibit differential significance in breast cancer growth and stemness , 2018, Experimental cell research.

[24]  Michael D. Brooks,et al.  Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. , 2018, Cell metabolism.

[25]  A. Ballabio,et al.  TFEB-mTORC1 feedback loop in metabolism and cancer , 2017, Cell stress.

[26]  C. Lopes,et al.  Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer. , 2017, Anticancer research.

[27]  Neel R Nabar,et al.  The Transcription Factor EB Links Cellular Stress to the Immune Response

 , 2017, The Yale journal of biology and medicine.

[28]  A. Ballabio,et al.  Transcription Factor EB Controls Metabolic Flexibility during Exercise , 2017, Cell metabolism.

[29]  J. Brugarolas,et al.  Multistep regulation of TFEB by MTORC1 , 2017, Autophagy.

[30]  A. Ballabio,et al.  TFEB at a glance , 2016, Journal of Cell Science.

[31]  C. Heeschen,et al.  Hallmarks of cancer stem cell metabolism , 2016, British Journal of Cancer.

[32]  Navdeep S. Chandel,et al.  Fundamentals of cancer metabolism , 2016, Science Advances.

[33]  J. Locasale,et al.  The Warburg Effect: How Does it Benefit Cancer Cells? , 2016, Trends in biochemical sciences.

[34]  O. Brady,et al.  TFEB and TFE3 are novel components of the integrated stress response , 2016, The EMBO journal.

[35]  G. Mills,et al.  Metabolic stress induces a Wnt-dependent cancer stem cell-like state transition , 2015, Cell Death and Disease.

[36]  Z. Ronai,et al.  UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. , 2015, Trends in biochemical sciences.

[37]  Chen Lin,et al.  Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC). , 2014, Cancer letters.

[38]  J. Menéndez,et al.  Metabostemness: A New Cancer Hallmark , 2014, Front. Oncol..

[39]  M. Todaro,et al.  Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment , 2014, Cell Death and Disease.

[40]  M. Ferrari,et al.  XBP1 Promotes Triple Negative Breast Cancer By Controlling the HIF1 α Pathway , 2014, Nature.

[41]  Jun Yao,et al.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. , 2013, Cancer cell.

[42]  John M. Asara,et al.  Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.

[43]  Nicolò Riggi,et al.  Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. , 2012, Genes & development.

[44]  Yong Chen,et al.  MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB , 2012, Autophagy.

[45]  M. Keating,et al.  Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells , 2011, The Journal of Biological Chemistry.

[46]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[47]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[48]  Seon-Mi Yu,et al.  Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes , 2010, Experimental & Molecular Medicine.

[49]  K. Pantel,et al.  Discovery of a novel unfolded protein response phenotype of cancer stem/progenitor cells from the bone marrow of breast cancer patients. , 2010, Journal of proteome research.

[50]  C. Eaves,et al.  Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. , 2010, Cancer research.

[51]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[52]  M. Ringnér,et al.  The CD44+/CD24- phenotype is enriched in basal-like breast tumors , 2008, Breast Cancer Research.

[53]  Tiruneh K. Hailemariam,et al.  Renal Carcinoma-associated Transcription Factors TFE3 and TFEB Are Leukemia Inhibitory Factor-responsive Transcription Activators of E-cadherin* , 2005, Journal of Biological Chemistry.